Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Osi Pharmaceuticals Inc (OSIP) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Osi Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 729922.
Total stock buying since 2010: $434,890,957.
Total stock sales since 2010: $17,117.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 7,563,321 | $434,890,957 | 298 | $17,117 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-06 | 7,563,321 | $434,890,957 | 298 | $17,117 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-06-07 | Ruby Acqusition, Inc. (10% Owner) | Buy | 6,387,295 | 57.50 | 367,269,462 |
| 2010-06-04 | Ruby Acqusition, Inc. (10% Owner) | Buy | 1,176,026 | 57.50 | 67,621,495 |
| 2010-06-01 | Davies Angela M. (Sr. VP and CMO, Oncology) | Sale | 298 | 57.44 | 17,117 |
Insider trading activities including stock purchases, stock sales, and option exercises of OSIP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Osi Pharmaceuticals Inc (symbol OSIP, CIK number 729922) see the Securities and Exchange Commission (SEC) website.